Beverly Tchang MD of Weill Cornell Medicine shares perspectives on today’s obesity trends, and touches on emerging innovative approaches from Noom, Weight Watchers, MyFitnessPal, LoseIt, as well as new medications such as Semaglutide (AKA Wegovy by Novo Nordisk).